fox5sandiego.com
Cure8 news brief
Why This Matters
Local university rankings matter because they spotlight research and faculty whose work can influence future treatments for autoimmune diseases like Crohn’s disease.
Who Should Pay Attention
Patients and caregivers interested in IBD or autoimmune research; clinicians and researchers tracking translational science from UC San Diego.
Study Snapshot
Story typeMainstream News
Evidence typePatient Education
Source depthFull source text
What To Know
UC San Diego was named No. 4 among U.S. public universities and cited for work by alumni and faculty connected to autoimmune disease research (Fred Ramsdell, linked to FOXp3 discoveries) and a new cancer drug (Rebecsinib) under study. The piece is a local news report about rankings and featured lab work, not a scientific paper or clinical trial result.
The article mentions basic research and an ongoing clinical trial of a cancer drug at UC San Diego, and notes that FOXp3 research contributed to therapies for autoimmune diseases including Crohn’s disease. It does not provide trial results, treatment recommendations, or new clinical guidelines.
Keep In Mind
The article is a local news piece summarizing rankings and highlighting affiliated researchers and a clinical trial; it does not report trial results or clinical guidance.
Source Details
Review the original publication for the complete reporting, methods, and context.
Publicationfox5sandiego.com
AuthorsRhea Caoile
Indexed viaGoogle News
Source typeWeb article
PublishedSep 3, 2026, 7:28 PM
Content availableFull source text
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Crohn's & Colitis Foundation hosts annual flag-football fundraiser at Ford Field - ClickOnDetroit
Fundraising events like this support research and patient services for people with Crohn’s disease and ulcerative colitis. They also raise public awareness about IBD, which can reduce stigma and increase community...
USA Today: Crohn's Disease Is a Lifelong Condition, But Proper Treatment Makes All the Difference
This article reassures people with Crohn’s that newer medications can control inflammation and lower complication and surgery risk. It also highlights the kinds of complications to watch for and ongoing research into...
Annual gala for Crohn's and Colitis research aims to raise $800K - SaportaReport
Fundraising events support IBD research, programs and patient services. Money raised can contribute to work on personalized treatments and diagnostic tools that might benefit people with Crohn’s disease or ulcerative...